Charles E. Cooley

Array ( [id] => 9254635 [patent_doc_number] => 08618051 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-31 [patent_title] => 'Vesiculins' [patent_app_type] => utility [patent_app_number] => 12/848835 [patent_app_country] => US [patent_app_date] => 2010-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 22557 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12848835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8995008 [patent_doc_number] => 08518892 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-27 [patent_title] => 'Methods to treat symptoms of pathophysiology related to body mass' [patent_app_type] => utility [patent_app_number] => 12/848308 [patent_app_country] => US [patent_app_date] => 2010-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 43 [patent_no_of_words] => 20306 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12848308 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6588754 [patent_doc_number] => 20100291579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses' [patent_app_type] => utility [patent_app_number] => 12/803671 [patent_app_country] => US [patent_app_date] => 2010-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 536 [patent_figures_cnt] => 536 [patent_no_of_words] => 216041 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12803671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9964994 [patent_doc_number] => 09012610 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-21 [patent_title] => 'Diagnostic kit for IGFBP-4 proteolytic fragments in a patient sample' [patent_app_type] => utility [patent_app_number] => 13/381230 [patent_app_country] => US [patent_app_date] => 2010-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 6891 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13381230 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8300977 [patent_doc_number] => 20120183536 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'METHODS OF USING CORTICOTROPIN-RELEASING FACTOR FOR THE TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 13/377810 [patent_app_country] => US [patent_app_date] => 2010-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 20885 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13377810 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6000693 [patent_doc_number] => 20110117095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'GROWTH FACTOR HTTER36' [patent_app_type] => utility [patent_app_number] => 12/818854 [patent_app_country] => US [patent_app_date] => 2010-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18801 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20110117095.pdf [firstpage_image] =>[orig_patent_app_number] => 12818854 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8053983 [patent_doc_number] => 20120076729 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'METHODS OF TREATING CANCERS' [patent_app_type] => utility [patent_app_number] => 13/375556 [patent_app_country] => US [patent_app_date] => 2010-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 20762 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20120076729.pdf [firstpage_image] =>[orig_patent_app_number] => 13375556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6615671 [patent_doc_number] => 20100310566 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'Fibroblast Growth Factor-Like Polypeptides' [patent_app_type] => utility [patent_app_number] => 12/791485 [patent_app_country] => US [patent_app_date] => 2010-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 27733 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0310/20100310566.pdf [firstpage_image] =>[orig_patent_app_number] => 12791485 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6096071 [patent_doc_number] => 20110003302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'Fibroblast Growth Factor-Like Polypeptides' [patent_app_type] => utility [patent_app_number] => 12/791510 [patent_app_country] => US [patent_app_date] => 2010-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 27740 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003302.pdf [firstpage_image] =>[orig_patent_app_number] => 12791510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6644197 [patent_doc_number] => 20100227823 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'METHODS FOR REGULATING ANGIOGENESIS AND VASCULAR INTEGRITY USING TRK RECEPTOR LIGANDS' [patent_app_type] => utility [patent_app_number] => 12/785183 [patent_app_country] => US [patent_app_date] => 2010-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14212 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20100227823.pdf [firstpage_image] =>[orig_patent_app_number] => 12785183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6265037 [patent_doc_number] => 20100297688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'METHOD FOR DIAGNOSING OR PREDICTING SHORT STATURE IN HUMANS' [patent_app_type] => utility [patent_app_number] => 12/783944 [patent_app_country] => US [patent_app_date] => 2010-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4533 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297688.pdf [firstpage_image] =>[orig_patent_app_number] => 12783944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8200944 [patent_doc_number] => 08188040 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-29 [patent_title] => 'FGF21 mutants and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/773266 [patent_app_country] => US [patent_app_date] => 2010-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 120 [patent_figures_cnt] => 121 [patent_no_of_words] => 41503 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/188/08188040.pdf [firstpage_image] =>[orig_patent_app_number] => 12773266 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7790513 [patent_doc_number] => 20120052069 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-01 [patent_title] => 'FGF21 MUTANTS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/318756 [patent_app_country] => US [patent_app_date] => 2010-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 120 [patent_figures_cnt] => 120 [patent_no_of_words] => 45531 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20120052069.pdf [firstpage_image] =>[orig_patent_app_number] => 13318756 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6531077 [patent_doc_number] => 20100221267 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'PDGFR BETA-SPECIFIC INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/764121 [patent_app_country] => US [patent_app_date] => 2010-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 18295 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20100221267.pdf [firstpage_image] =>[orig_patent_app_number] => 12764121 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6616138 [patent_doc_number] => 20100323962 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'Method of Reduction of Wrinkles on Skin, Darkening of Hair and Acceleration of Wound Healing by Applying Peptides Related to Basic Fibroblast Growth Factor (bFGF)' [patent_app_type] => utility [patent_app_number] => 12/764530 [patent_app_country] => US [patent_app_date] => 2010-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 2046 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0323/20100323962.pdf [firstpage_image] =>[orig_patent_app_number] => 12764530 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9831880 [patent_doc_number] => 08940693 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-27 [patent_title] => 'Protein for the immunocastration for mammals' [patent_app_type] => utility [patent_app_number] => 13/262265 [patent_app_country] => US [patent_app_date] => 2010-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 4580 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13262265 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7579719 [patent_doc_number] => 20110293602 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'VEGF-LIKE FACTOR ANTIBODIES AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/729708 [patent_app_country] => US [patent_app_date] => 2010-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5497 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20110293602.pdf [firstpage_image] =>[orig_patent_app_number] => 12729708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7817471 [patent_doc_number] => 20120064091 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'DYSFUNCTION OF THE MITOCHONDRIAL RESPIRATORY CHAIN, METHODS FOR DIAGNOSIS, TREATMENT AND FOLLOW-UP' [patent_app_type] => utility [patent_app_number] => 13/259125 [patent_app_country] => US [patent_app_date] => 2010-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11223 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20120064091.pdf [firstpage_image] =>[orig_patent_app_number] => 13259125 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9662520 [patent_doc_number] => 08809499 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-19 [patent_title] => 'Fusion protein of human fibroblast growth factor-21 and exendin-4' [patent_app_type] => utility [patent_app_number] => 13/391226 [patent_app_country] => US [patent_app_date] => 2010-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 9212 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13391226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7490818 [patent_doc_number] => 08030275 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-04 [patent_title] => 'Methods for treating obesity using fibroblast growth factor-like polypeptides' [patent_app_type] => utility [patent_app_number] => 12/721495 [patent_app_country] => US [patent_app_date] => 2010-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 30299 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/030/08030275.pdf [firstpage_image] =>[orig_patent_app_number] => 12721495 [rel_patent_id] =>[rel_patent_doc_number] =>)